These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17460714)

  • 1. Assessment of single versus twice daily dosing of ramipril by ambulatory blood pressure monitoring in patients similar to those included in the HOPE study.
    Goyal D; Chong AY; Watson RL; Prasad N; Watson RD
    J Hum Hypertens; 2007 Jul; 21(7):525-30. PubMed ID: 17460714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB; Cleveland JM; Rolleri RL;
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.
    Svensson P; de Faire U; Sleight P; Yusuf S; Ostergren J
    Hypertension; 2001 Dec; 38(6):E28-32. PubMed ID: 11751742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
    Gerstein HC
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
    J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
    Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
    Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
    Hathial M
    Indian Heart J; 2008; 60(3):200-4. PubMed ID: 19240307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring.
    Uchaipichat V; Koanantakul B; Suthisisang C
    J Med Assoc Thai; 2008 Sep; 91(9):1468-77. PubMed ID: 18843880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J; Lonn E; Pogue J; Arnold JM; Dagenais GR; Yusuf S;
    Circulation; 2005 Aug; 112(9):1339-46. PubMed ID: 16129815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large prospective study of ramipril in patients with hypertension. CARE Investigators.
    Kaplan NM; Sproul LE; Mulcahy WS
    Clin Ther; 1993; 15(5):810-8. PubMed ID: 8269447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the efficacy of felodipine given once or twice daily in the management of elderly hypertensive patients.
    Morgan T; Morgan O; Anderson A
    J Hum Hypertens; 1996 Mar; 10(3):193-7. PubMed ID: 8733039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC; Ayala DE; Khder Y; Calvo C
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of ramipril 10 mg in patients at high risk of cardiovascular events: an observational study.
    Hathial M
    J Indian Med Assoc; 2008 Jul; 106(7):468-70, 480. PubMed ID: 18975506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of ramipril 10 mg daily in high-risk cardiovascular patients in Taiwan: experience from Kaohsiung Medical University Chung-Ho Memorial Hospital.
    Chu CS; Cheng KH; Lee KT; Lin TH; Lee ST; Su HM; Voon WC; Sheu SH; Lai WT
    Kaohsiung J Med Sci; 2005 Nov; 21(11):511-6. PubMed ID: 16358553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.